O

Ortivus AB
STO:ORTI B

Watchlist Manager
Ortivus AB
STO:ORTI B
Watchlist
Price: 1.44 SEK 2.86%
Market Cap: 63.8m SEK
Have any thoughts about
Ortivus AB?
Write Note

Ortivus AB
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ortivus AB
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
O
Ortivus AB
STO:ORTI B
Additional Paid In Capital
kr32.8m
CAGR 3-Years
0%
CAGR 5-Years
17%
CAGR 10-Years
N/A
RaySearch Laboratories AB (publ)
STO:RAY B
Additional Paid In Capital
kr2m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mentice AB
STO:MNTC
Additional Paid In Capital
kr201.4m
CAGR 3-Years
12%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Additional Paid In Capital
kr361.5m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ortivus AB
Glance View

Market Cap
63.8m SEK
Industry
Health Care

Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

ORTI B Intrinsic Value
2.27 SEK
Undervaluation 37%
Intrinsic Value
Price
O

See Also

What is Ortivus AB's Additional Paid In Capital?
Additional Paid In Capital
32.8m SEK

Based on the financial report for Dec 31, 2023, Ortivus AB's Additional Paid In Capital amounts to 32.8m SEK.

What is Ortivus AB's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
17%

Over the last year, the Additional Paid In Capital growth was 0%.

Back to Top